Skip to content
Disclosery

Broadfin Capital, LLC

Follow

13F filer, CIK 1511901, New York, NY

Broadfin Capital, LLC reported $635,216,000 across 45 holdings for the quarter ended 2018-06-30, in a 13F-HR filed 2018-08-14. Its ten largest share positions make up 56.53% of the portfolio.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001511901-18-000005

Period
2018-06-30
Reported value
$635M
Holdings
45
Top 10 weight
56.53%
New
19
Sold out
25

Largest buys vs the previous quarter

SecurityShares changeApprox. value
IOVAadded+3,233,618$41.4M
ENDO INTL PLCnew+2,591,573$24.4M
EXASnew+261,400$15.6M
TNDMnew+570,598$12.6M
XRAYnew+262,900$11.5M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
HRTXreduced-1,061,629-$41.2M
MIRATI THERAPEUTICS INCreduced-423,770-$20.9M
HORIZON PHARMA PLCreduced-1,224,600-$20.3M
GW PHARMACEUTICALS PLCexited-175,030-$19.7M
ANGOexited-911,707-$15.7M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q2 2018

Share positions as resolved from 13F-HR 0001511901-18-000005, largest first. % of portfolio is the value over $594,801,000, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
IOVAIOVANCE BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 912,987 shares; 2018Q2: 4,146,605 shares 4,146,605$53.1M8.92%+3,233,618Timeline
MIRATI THERAPEUTICS INCMIRATI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 1,443,948 shares; 2018Q2: 1,020,178 shares 1,020,178$50.3M8.46%-423,770
LA JOLLA PHARMACEUTICAL COLA JOLLA PHARMACEUTICAL COQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 1,656,720 shares; 2018Q2: 1,494,520 shares 1,494,520$43.6M7.33%-162,200
ADAMAS PHARMACEUTICALS INCADAMAS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 1,135,203 shares; 2018Q2: 1,417,121 shares 1,417,121$36.6M6.15%+281,918
CORIUM INTL INCCORIUM INTL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 3,119,645 shares; 2018Q2: 3,597,057 shares 3,597,057$28.8M4.84%+477,412
RETROPHIN INCRETROPHIN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 1,178,226 shares; 2018Q2: 1,048,693 shares 1,048,693$28.6M4.81%-129,533
ZOGENIX INC.ZOGENIX INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 537,380 shares; 2018Q2: 622,380 shares 622,380$27.5M4.62%+85,000
ENDO INTL PLCENDO INTL PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: 2,591,573 shares 2,591,573$24.4M4.11%new
HORIZON PHARMA PLCHORIZON PHARMA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 2,564,175 shares; 2018Q2: 1,339,575 shares 1,339,575$22.2M3.73%-1,224,600
CPRXCATALYST PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 6,812,764 shares; 2018Q2: 6,772,764 shares 6,772,764$21.1M3.55%-40,000Timeline
HRTXHERON THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 1,581,416 shares; 2018Q2: 519,787 shares 519,787$20.2M3.4%-1,061,629Timeline
ARATANA THERAPEUTICS INCARATANA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 4,294,426 shares; 2018Q2: 4,294,426 shares 4,294,426$18.3M3.07%0
AVADEL PHARMACEUTICALS, PLCAVADEL PHARMACEUTICALS, PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 2,624,663 shares; 2018Q2: 2,724,663 shares 2,724,663$16.7M2.81%+100,000
EXASEXACT SCIENCES CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: 261,400 shares 261,400$15.6M2.63%newTimeline
ADMAADMA BIOLOGICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 720,529 shares; 2018Q2: 3,249,829 shares 3,249,829$14.7M2.46%+2,529,300Timeline
STRONGBRIDGE BIOPHARMA PLCSTRONGBRIDGE BIOPHARMA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 2,793,752 shares; 2018Q2: 2,340,649 shares 2,340,649$14M2.36%-453,103
BIODELIVERY SCIENCES INTL INBIODELIVERY SCIENCES INTL INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 4,278,819 shares; 2018Q2: 4,278,819 shares 4,278,819$12.6M2.12%0
TNDMTANDEM DIABETES CARE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: 570,598 shares 570,598$12.6M2.11%newTimeline
ANTARES PHARMA INCANTARES PHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 4,673,247 shares; 2018Q2: 4,623,247 shares 4,623,247$11.9M2.01%-50,000
XRAYDENTSPLY SIRONA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: 262,900 shares 262,900$11.5M1.93%newTimeline
IARTINTEGRA LIFESCIENCES HLDGS CQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 298,424 shares; 2018Q2: 163,424 shares 163,424$10.5M1.77%-135,000Timeline
TELIGENT INC NEWTELIGENT INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 1,690,794 shares; 2018Q2: 2,999,817 shares 2,999,817$10.4M1.74%+1,309,023
SOCIETAL CDMO INCSOCIETAL CDMO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 2,236,025 shares; 2018Q2: 2,048,025 shares 2,048,025$10.3M1.73%-188,000
KALA BIO INC COMKALA BIO INC COMQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 681,239 shares; 2018Q2: 598,586 shares 598,586$8.22M1.38%-82,653
LIVNLIVANOVA PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: 72,100 shares 72,100$7.2M1.21%newTimeline
NOVELION THERAPEUTICS INCNOVELION THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 1,948,554 shares; 2018Q2: 1,948,554 shares 1,948,554$7.17M1.21%0
MTDMETTLER TOLEDO INTERNATIONALQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: 11,900 shares 11,900$6.89M1.16%newTimeline
SIERRA ONCOLOGY INCSIERRA ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: 2,106,589 shares 2,106,589$6.24M1.05%new
STRATA SKIN SCIENCES INCSTRATA SKIN SCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 203,346 shares; 2018Q2: 2,943,819 shares 2,943,819$6.04M1.01%+2,740,473
PERNIX THERAPEUTICS HLDGS INPERNIX THERAPEUTICS HLDGS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 15,000,000 shares; 2018Q2: 15,000,000 shares 15,000,000$5.15M0.87%0
SOL GEL TECHNOLOGIESSOL GEL TECHNOLOGIESQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 647,700 shares; 2018Q2: 647,700 shares 647,700$5M0.84%0
XERIS PHARMACEUTICALS INCXERIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: 250,000 shares 250,000$4.75M0.8%new
PACBPACIFIC BIOSCIENCES CALIF INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: 1,054,091 shares 1,054,091$3.74M0.63%newTimeline
GLOBAL BLOOD THERAPEUTICS U…GLOBAL BLOOD THERAPEUTICS USDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: 80,100 shares 80,100$3.62M0.61%new
QUOTIENT LTDQUOTIENT LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: 439,700 shares 439,700$3.53M0.59%new
ATECALPHATEC HLDGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: 1,111,112 shares 1,111,112$3.31M0.56%newTimeline
MEDIWOUND LTDMEDIWOUND LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 500,000 shares; 2018Q2: 477,100 shares 477,100$3.29M0.55%-22,900
SCYNEXIS INC COM NEWSCYNEXIS INC COM NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: 1,885,904 shares; 2018Q2: 1,885,904 shares 1,885,904$3.09M0.52%0
ODONATE THERAPEUTICS INCODONATE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2016Q3: restricted; 2016Q4: restricted; 2017Q1: restricted; 2017Q2: restricted; 2017Q3: restricted; 2017Q4: restricted; 2018Q1: not reported; 2018Q2: 93,081 shares 93,081$2.06M0.35%new

Options

Puts and calls, as filed. The amount and value describe the underlying shares, not the option premium, so they stay out of % of portfolio (H5).

SecurityTypeAmountValueChange
ZOGENIX INC.ZOGENIX INC. Common Stockput335,000$14.8Mnew
ENDO INTL PLCENDO INTL PLC SHScall1,200,000$11.3Mnew
TESARO INCTESARO INC COMcall125,000$5.56Mnew
AMARIN CORP PLCAMARIN CORP PLC SPONS ADR NEWcall1,455,000$4.5Mnew
HRTXHERON THERAPEUTICS INC COMcall100,000$3.88Mnew
IOVAIOVANCE BIOTHERAPEUTICS INC COMcall27,500$352Knew

Sold out in Q2 2018

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
GW PHARMACEUTICALS PLCGW PHARMACEUTICALS PLC175,030$19.7Mshares
ANGOANGIODYNAMICS INC911,707$15.7Mshares
NUVASIVE INCNUVASIVE INC258,292$13.5Mshares
AMAG PHARMACEUTICALS INCAMAG PHARMACEUTICALS INC598,800$12.1Mshares
GKOSGLAUKOS CORP293,900$9.06Mshares
ANABANAPTYSBIO INC79,200$8.24Mshares
CIGNA CORPORATIONCIGNA CORPORATION42,600$7.15Mshares
MRKMERCK & CO INC130,900$7.13Mshares
VCELVERICEL CORP658,900$6.56Mshares
ESPRESPERION THERAPEUTICS INC NE86,786$6.28Mshares
AMARIN CORP PLCAMARIN CORP PLC2,078,799$6.26Mshares
PARATEK PHARMACEUTICALS INCPARATEK PHARMACEUTICALS INC477,607$6.21Mshares
PCRXPACIRA BIOSCIENCES INC166,500$5.19Mshares
OXFORD IMMUNOTEC GLOBAL PLCOXFORD IMMUNOTEC GLOBAL PLC374,233$4.66Mshares
HORIZON PHARMA PLCHORIZON PHARMA PLC300,000$4.26Mcall
NATUS MEDICAL INCNATUS MEDICAL INC113,526$3.82Mshares
PROGENICS PHARMACEUTICALS INPROGENICS PHARMACEUTICALS IN500,000$3.73Mcall
VARIAN MED SYS INCVARIAN MED SYS INC30,000$3.68Mshares
INVITAE CORPINVITAE CORP750,000$3.52Mshares
VCYTVERACYTE INC600,658$3.34Mshares
TETRAPHASE PHARMACEUTICALS …TETRAPHASE PHARMACEUTICALS INC1,048,642$3.22Mshares
CIDARA THERAPEUTICS INC COM…CIDARA THERAPEUTICS INC COM NEW375,816$1.5Mshares
INVUITY INCINVUITY INC298,800$1.15Mshares
CONTRAFECT CORPCONTRAFECT CORP389,475$633Kshares
OVASCIENCE INCOVASCIENCE INC545,282$442Kshares

How Q2 2018 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001511901-18-000005 base2018-08-14acceptance time not in the bulk data set